And compared with RBMS3 inhibition, knockdown of circHECTD1 (using sh-circHECTD1-2 plasmid with higher transfection efficiency) effectively increased the VM formation capacity of GBM cells (Supplementary Fig. 2). The gene discussed is RBMS3; the disease is glioblastoma.